top of page

$0.15

chg

-0.03 (-15.36%)

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

0.127

52 wk hi

2.87

Cash

$100.2M

Burn Rate (Qtr)

$15.9M

Mkt Cap

$10.2m

Avg Volume

7,916,689

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

APTX

BPIQ_Logo_RGB-01.jpg

Company Profile

Through our drug development expertise in brain & CNS disorders, we have developed a unique medicinal chemistry platform to discover novel product candidates. The compounds we have discovered work through modulation of NMDA receptors to avoid caustic effects associated with over-activation or full inhibition.

Recent Posts

See what the community is saying - click to see full post.

bottom of page